Mwanzo600276 • SHA
add
Jiangsu Hengrui Pharmaceuticals Co Ltd
Bei iliyotangulia
¥ 42.81
Bei za siku
¥ 42.81 - ¥ 44.41
Bei za mwaka
¥ 35.51 - ¥ 57.53
Thamani ya kampuni katika soko
272.19B CNY
Wastani wa hisa zilizouzwa
33.93M
Uwiano wa bei na mapato
52.11
Mgao wa faida
0.45%
Ubadilishanaji wa msingi
SHA
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 6.59B | 12.72% |
Matumizi ya uendeshaji wa biashara | 4.20B | 13.57% |
Mapato halisi | 1.19B | 1.91% |
Kiwango cha faida halisi | 18.03 | -9.58% |
Mapato kwa kila hisa | 0.17 | — |
EBITDA | 1.58B | 13.11% |
Asilimia ya kodi ya mapato | 11.01% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 22.91B | 30.03% |
Jumla ya mali | 48.34B | 12.75% |
Jumla ya dhima | 4.01B | 50.35% |
Jumla ya hisa | 44.33B | — |
hisa zilizosalia | 6.27B | — |
Uwiano wa bei na thamani | 6.13 | — |
Faida inayotokana na mali | 7.34% | — |
Faida inayotokana mtaji | 8.08% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 1.19B | 1.91% |
Pesa kutokana na shughuli | 1.55B | 8.31% |
Pesa kutokana na uwekezaji | -349.85M | -246.15% |
Pesa kutokana na ufadhili | -1.37B | -192.22% |
Mabadiliko halisi ya pesa taslimu | -180.50M | -115.08% |
Mtiririko huru wa pesa | -1.25B | -2,147.47% |
Kuhusu
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Ilianzishwa
28 Apr 1997
Tovuti
Wafanyakazi
19,611